ArticleJournal of medical signals and sensors2026
Monitoring the Adverse Implications of Coronavirus 2019-induced Pulmonary Complications on Patients' Respiratory Capacity and Physical Abilities with Moderate and Severe Signs during Interval Follow-up.
Article in Journal of medical signals and sensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The respiratory system of individuals with coronavirus 2019 (COVID-19) experiences significant strain due to the body's immunological response and inflammation, leading to organ failure. Over time, patients have improvement in symptoms such as radiological abnormalities, pulmonary function impairment, and decline in respiratory and physical abilities. This research aimed to assess the impact of COVID-19 on the pulmonary function and physiological performance capacity of patients with moderate and severe problems who were hospitalized and subsequently released. These parameters were evaluated during 3, 6, and 12-month follow-up periods. Methods: The participants in this research were individuals hospitalized with COVID-19 at Hajar Shahrekord Hospital. They evaluated using spirometry tests, a 6-min walk test (6MWT), and spiral lung high-resolution computed tomography (HRCT) scans. The assessments were conducted from their first diagnosis until 12 months after release. The sampling was performed employing the head-counting approach, and an expert examined the data collected from spirometry and 6MWT in statistics and epidemiology. Expert radiologists and pulmonologists examined spiral lung HRCT data. Results: The combined data from spirometry (revealing improved lung function), the 6MWT (showing increased endurance), and HRCT (indicating reduced lung damage) demonstrated marked progress in both groups throughout the study period. While each group demonstrated statistically significant improvements at various follow-up points, no significant difference emerged between the moderate and severe patient groups in the study. Significant improvements in lung function, physical capacity, and radiological outcomes were observed in both moderate and severe COVID-19 patients at the 12-month follow-up. Notably, there were no statistically significant differences in improvement between the groups. Conclusion: This study emphasizes the importance of personalized extended care and rehabilitation for patients severely affected by COVID-19, aiming to tackle ongoing deficits and prevent long-term complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.